▲ Dongkuk Industries = Announced the decision to invest 88 billion KRW in new facilities.
▲ IOK = Announced that 2,008,032 shares will be newly listed due to the exercise of the warrant on the 17th series of 1.5 billion KRW unnamed, interest-free, unsecured private convertible bonds.
▲ Vaxcell Bio = Announced the early termination of a randomized Phase 2 clinical trial comparing dendritic cells combined with lenalidomide and dexamethasone therapy or lenalidomide and dexamethasone combination therapy.
▲ Melpas = Announced the withdrawal of the extraordinary general meeting of shareholders scheduled for the 29th of next month.
▲ HLB = Announced participation in the rights offering of its subsidiary Elevar Therapeutics, Inc.
▲ 6il CNS = Announced the disposal of an idle factory in Gongdan-dong, Gumi-si, Gyeongbuk, valued at 2.8 billion KRW.
▲ LIS = Korea Exchange KOSDAQ Market Division announced a preliminary designation of LIS as an unfaithful disclosure corporation due to reversal of disclosure including withdrawal of the decision to issue convertible bonds.
▲ Polaris Uno = Announced the decision to conduct a stock dividend issuing 3 shares for every 1 common share.
▲ Prostemics = Announced the acquisition and resale of the 2nd series of 2 billion KRW unnamed, interest-bearing, unsecured private convertible bonds to improve financial structure and secure operating funds.
▲ EMTEC = Korea Exchange KOSDAQ Market Division announced a preliminary designation of EMTEC as an unfaithful disclosure corporation due to delayed disclosure of a stock pledge contract involving a change in the largest shareholder.
▲ Prostemics = Announced the decision to issue convertible bonds worth 5 billion KRW to secure operating funds and debt repayment funds.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
